PAMELA LOLLEY: Open Payments
NPI 1902158900 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 14 payments from 11 companies in 2025. Trend: 2023 $143 · 2024 $15 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $68 |
| Ethicon US, LLC | 1 | $48 |
| ABBVIE INC. | 2 | $48 |
| Dexcom, Inc. | 1 | $30 |
| Abbott Laboratories | 1 | $29 |
| PFIZER INC. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
| Davol Inc. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
Products named: STRATAFIX, Ozempic, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, QULIPTA, ELIQUIS, UBRELVY, Tirosint.
Industry payments across AL — which companies pay providers there.
